Company: IMNN
Filing Date: 2025-05-13
Form Type: S-1/A
Source: 0001641172-25-009814
Chunk: 7

Company: Imunon, Inc.
Filing Date: 2025-05-13
Form: S-1/A
Chunk 7
---
 any other trading system.

You should read this prospectus, together with additional information described under the headings “ Incorporation of Certain Information by Reference” and “ Where You Can Find More Information,” carefully before you invest in any of our securities.

Investing in our securities involves a high degree of risk. You should only purchase shares if you can afford the loss of your investment. If we fail to regain compliance with Nasdaq’s continued listing requirements, which requires the closing bid price of our Common Stock to be $1.00 per share or more for a minimum of ten (10) consecutive business days before May 27, 2025, Nasdaq may delist our Common Stock. Nasdaq may also delist our Common Stock for public interest concerns resulting from the dilutive impact and terms of the common warrants in this offering. Our independent registered public accountant has issued an audit opinion which includes a statement expressing substantial doubt as to our ability to continue as a going concern. See “ Risk Factors” on page 6 of this prospectus and the section entitled “ Risk Factors” included in our most recent Annual Report on Form 10-K, as revised or supplemented by our subsequent Quarterly Reports on Form 10-Q, which are incorporated herein by reference, for a discussion of information that you should consider before investing in our securities.

Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

|                           |     | Per          
 Share and    
 Accompanying 
 Common       
 Warrant      |     | Per          
 Pre-Funded   
 Warrant and  
 Accompanying 
 Common       
 Warrant      |     | Total |
|:--------------------------|:----|:-------------|:----|:-------------|:----|:------|
| Public                    
 offering price(1)         |     | $            |     | $            |     | $     |
| Placement                 
 Agent fees(2)             |     | $            |     | $            |     | $     |
| Proceeds                  
 to us, before expenses(3) |     | $            |     | $            |     | $     |

| (1) | The                                                             
 combined public offering price is $                             
 per share of Common Stock and accompanying common warrant (or $ 
 per pre-funded warrant and accompanying common warrant).        |

| (2) | Represents                                                                                                                       
 a cash fee equal to seven percent (7.0%)